Nevertheless, a study involving a large patient cohort and healthy controls demonstrated that the levels of anti‐MUC1 autoantibodies in patient sera are similar to those of healthy controls, suggesting that autoimmunity to MUC1 in breast cancer may not be enhanced.9 Here, MUC1 is linked to breast cancer.